FDA Experts Push For Wider Anti-Overdose Drug Availability
While experts at a U.S. Food and Drug Administration meeting Thursday advocated broader availability for a prescription painkiller overdose antidote, they emphasized the need for additional clinical trials before releasing the drug...To view the full article, register now.
Already a subscriber? Click here to view full article